Zobrazeno 1 - 10
of 13
pro vyhledávání: '"Paula Gonzalez Villarroel"'
Autor:
Ana Fernández Montes, Alberto Carmona-Bayonas, Paula Jimenez-Fonseca, Francisca Vázquez Rivera, Nieves Martinez Lago, Marta Covela Rúa, Antía Cousillas Castiñeiras, Paula Gonzalez Villarroel, Juan De la Cámara Gómez, José Carlos Méndez Méndez, Carmen Carriles Fernández, Manuel Sanchez Cánovas, Teresa Garcia García
Publikováno v:
Scientific Reports, Vol 11, Iss 1, Pp 1-10 (2021)
Abstract Trifluridine/tipiracil increases overall survival (OS) in patients with refractory, metastatic colorectal cancer (mCRC). A post hoc exploratory analysis of the RECOURSE randomized clinical trial (RCT) established two categories, a good progn
Externí odkaz:
https://doaj.org/article/79955248229f4b8ab9ff4d86bc53b994
Autor:
T. García, Juan de la Cámara Gómez, Alberto Carmona-Bayonas, Marta Covela Rúa, Francisca Vázquez Rivera, Paula Jiménez-Fonseca, Manuel Cánovas, Ana Montes, Carmen Carriles Fernández, Paula Gonzalez Villarroel, Nieves Martinez Lago, Antía Cousillas Castiñeiras, J. Méndez
Publikováno v:
Scientific Reports, Vol 11, Iss 1, Pp 1-10 (2021)
Scientific Reports
Scientific Reports
Trifluridine/tipiracil increases overall survival (OS) in patients with refractory, metastatic colorectal cancer (mCRC). A post hoc exploratory analysis of the RECOURSE randomized clinical trial (RCT) established two categories, a good prognosis corr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a9ba7e763c6b00042f89c47722807250
https://doaj.org/article/79955248229f4b8ab9ff4d86bc53b994
https://doaj.org/article/79955248229f4b8ab9ff4d86bc53b994
Autor:
Carlos Romero Reinoso, Paula Gonzalez Villarroel, Juan de la Cámara Gómez, Ana Montes, Mónica Jorge Fernández, Jose Carlos Mendez, Manuel Valladares Ayerbes, Margarida Reboredo López, Mari Luz Pellón Augusto, Mercedes Salgado Fernández, Manuel Ramos Vázquez, Guillermo Alfonso Quintero Aldana, Marta Covela Rúa
Publikováno v:
Journal of geriatric oncology. 11(8)
Background Despite the high morbidity and mortality of metastatic colorectal cancer (mCRC) in older patients, they have been underrepresented in clinical trials and their optimal treatment is yet to be determined. This open-label phase II study evalu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cd82eb8a09073d05b0cb643d8f487b23
https://pubmed.ncbi.nlm.nih.gov/34507891
https://pubmed.ncbi.nlm.nih.gov/34507891
Autor:
Lidia Vázquez Tuñas, Guillermo Alfonso Quintero Aldana, Paula Gonzalez Villarroel, Manuel Valladares Ayerbes, Mercedes Salgado Fernández, Ana Fernández Montes, Mónica Jorge Fernández, Juan de la Cámara Gómez
Publikováno v:
Journal of Cancer Research and Therapeutics, Vol 13, Iss 2, Pp 240-245 (2017)
Background: Recent studies support the use of gemcitabine and nab-paclitaxel in adults with locally advanced unresectable or metastatic pancreatic adenocarcinoma although insufficient data are available on prognostic and predictive markers of respons
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::788375f5724453113cd054d9d2f2ffa7
http://www.cancerjournal.net/article.asp?issn=0973-1482
http://www.cancerjournal.net/article.asp?issn=0973-1482
Autor:
Carlos Méndez Méndez, Begoña Graña Suárez, Sonia Candamio Folgar, Guillermo Alfonso Quintero Aldana, Paula Gonzalez Villarroel, Marta Covela Rúa, Elena Brozos Vazquez, Carlos Grande Ventura, Juan de la Cámara Gómez, Alberto Carral Maseda, Francisca Vázquez Rivera, Mercedes Salgado Fernández, Mónica Jorge Fernández, Marta Carmona Campos, Margarita Reboredo Lopez, Antia Cousillas Castiñeira, Ana Montes, Elena Gallardo Martin, Nieves Martinez Lago, Maria Luz Pellon Augusto
Publikováno v:
Journal of Clinical Oncology. 37:620-620
620 Background: Activating B-type Raf kinase (BRAF) mutations, mostly missense V600E, occur in approximately 8% to 12% of patients with metastatic colorectal cancer (mCRC). BRAF (V600E)mt is a strong predictor of a poor prognosis, with distinct clini
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::623bf7a71c92469aef834ed576adf8f2
https://doi.org/10.1200/jco.2019.37.4_suppl.620
https://doi.org/10.1200/jco.2019.37.4_suppl.620
Autor:
Begoña Graña Suárez, Juan de la Cámara Gómez, Carlos Méndez Méndez, Elena Gallardo Martin, Nieves Martinez Lago, Maria Luz Pellon Augusto, Margarita Reboredo Lopez, Antia Cousillas Castiñeira, Sonia Candamio Folgar, Carlos Grande Ventura, Guillermo Alfonso Quintero Aldana, Paula Gonzalez Villarroel, Elena Brozos Vazquez, Mónica Jorge Fernández, Marta Covela Rúa, Ana Montes, Francisca Vázquez Rivera, Marta Carmona Campos, Mercedes Salgado Fernández, Alberto Carral Maseda
Publikováno v:
Journal of Clinical Oncology. 37:622-622
622 Background: Multiple studies have reported prognostic association of neutrophil to lymphocyte ratio (NLR), platelet to lymphocyte ratio (PLT) and albumin levels including patients with early and advanced metastatic colorectal cancer. However, it
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::dca78e5125cb930a836192fbfd79fcbf
https://doi.org/10.1200/jco.2019.37.4_suppl.622
https://doi.org/10.1200/jco.2019.37.4_suppl.622
Autor:
Mercedes Salgado Fernández, Antia Cousillas, Elena Brozos Vazquez, Mónica Jorge Fernández, Maria Luz Pellon Augusto, Begoña Graña, Ana Montes, Yolanda Vidal Insua, Paula Gonzalez Villarroel, Carlos Romero Reinoso, Marta Carmona Campos, Jose Carlos Mendez, Juan De la camara, Francisca Vázquez Rivera, Guillermo Alfonso Quintero Aldana, Sonia Candamio Folgar, Elena Gallardo Martin, Nieves Martinez Lago, Marta Covela Rúa, Margarita Reboredo Lopez
Publikováno v:
Journal of Clinical Oncology. 36:e15561-e15561
e15561Background: BRAF mutations, mostly missense V600E, occur in approximately 8% to 12% of patients with metastatic colorectal cancer (mCRC). BRAF (V600E) mt is a strong predictor of a poor progn...
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e48e4b5a359b686863703bd0f12ecb3e
https://doi.org/10.1200/jco.2018.36.15_suppl.e15561
https://doi.org/10.1200/jco.2018.36.15_suppl.e15561
Autor:
M. Gentil González, J. Carrasco Álvarez, I. Fernández Pérez, Paula Gonzalez Villarroel, C. López Jato, L. Vázquez Tuñas, B. Carnero López
Publikováno v:
Oncología (Barcelona) v.30 n.3 2007
SciELO España. Revistas Científicas Españolas de Ciencias de la Salud
instname
SciELO España. Revistas Científicas Españolas de Ciencias de la Salud
instname
La gliomatosis cerebri (GC) constituye un raro proceso neoplásico cerebral primario de crecimiento difuso, infiltrativo y no destructivo, de naturaleza glial. El término GC implica afectación de al menos dos lóbulos cerebrales con posible extensi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::16bd3019999a3c1fafb15145b94cf48e
http://scielo.isciii.es/scielo.php?script=sci_arttext&pid=S0378-48352007000300005
http://scielo.isciii.es/scielo.php?script=sci_arttext&pid=S0378-48352007000300005
Autor:
Lidia Vazquez Tuñas, Mercedes Salgado Fernández, Juan de la Cámara Gómez, Guillermo Quintero, Paula Gonzalez Villarroel, Ana Montes, Mónica Jorge Fernández, Manuel Valladares Ayerbes
Publikováno v:
Journal of Clinical Oncology. 33:483-483
483 Background: Placement of a biliary stent is a standard measure for patients (pts) with pancreatic cancer. We evaluated prognostic/predictive factors that could predict the benefit of gemcitabine/nabpaclitaxel in pts with locally advanced unresect
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3bf26b53db9c28c98ab6eb5c2ce3f173
https://doi.org/10.1200/jco.2015.33.3_suppl.483
https://doi.org/10.1200/jco.2015.33.3_suppl.483
Autor:
Nieves Martínez-Lago, Ana Fernández-Montes, Marta Covela, Elena M. Brozos, Juan De la Cámara, José C. Méndez Méndez, Mónica Jorge-Fernández, Antía Cousillas Castiñeiras, Cristina Reboredo, David Arias Ron, María L. Pellón Augusto, Paula González Villarroel, Begoña Graña, Mercedes Salgado Fernández, Alberto Carral Maseda, Francisca Vázquez Rivera, Sonia Candamio Folgar, Margarita Reboredo López, On behalf of the Galician Research Group on Digestive Tumors (GITuD)
Publikováno v:
BMC Cancer, Vol 21, Iss 1, Pp 1-10 (2021)
Abstract Background Outcomes are poorer in metastatic colorectal cancer (mCRC) patients with BRAF V600E mutations than those without it, but the effect of these mutations on treatment response is unclear. This real-world study assessed the effects of
Externí odkaz:
https://doaj.org/article/0205a0ed5fdf486f96be2430c7159205